Literature DB >> 11518681

Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.

O Kobayashi1, H Miwa, S Watanabe, M Tsujii, R N Dubois, N Sato.   

Abstract

Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression has been demonstrated in inflamed intestinal mucosa. Although regulation of COX-2 and iNOS expression has been studied extensively, the interplay between these two enzymes remains unclear. Because they play crucial roles in inflammation and/or carcinogenesis, we investigated whether COX-2 regulates iNOS expression and evaluated the effects of COX-2 inhibitor and arachidonic acid (AA) on iNOS induction. The COX-2 gene coding region was stably transfected into rat intestinal epithelial cells (RIE sense cells). After interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS) administration, iNOS and COX-2 expression was evaluated by Western blotting. PGE(2) was measured by the enzyme immunoassay (EIA) method. Expression of IFN response factor-1, phosphorylated extracellular signal-related kinase-1 and -2, and Ikappa-Balpha was evaluated. Activator protein-1 and nuclear factor-kappaB (NF-kappaB) were examined by gel mobility shift assay; a supershift assay was performed to identify the NF-kappaB complex components. JTE-522 or AA was added before IFN-gamma and LPS administration, and effects on iNOS and PGE(2) induction were evaluated by Western blotting or EIA. iNOS protein and mRNA expression was inhibited in RIE sense cells. Although NF-kappaB activation was suppressed and Ikappa-Balpha protein was more stable, respectively, in RIE sense cells, no difference was noted in other transcription factors. JTE-522 increased iNOS protein expression in RIE cells. We conclude that COX-2 suppressed iNOS expression in RIE cells through suppression of NF-kappaB by stabilizing Ikappa-Balpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518681     DOI: 10.1152/ajpgi.2001.281.3.G688

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  6 in total

1.  Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice.

Authors:  Bruce A Vallance; Wanyin Deng; Myriam De Grado; Crystal Chan; Kevan Jacobson; B Brett Finlay
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 2.  iNOS expression in oral and gastrointestinal tract mucosa.

Authors:  Nurullah Keklikoglu; Meltem Koray; Humeyra Kocaelli; Sevtap Akinci
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

3.  Cyclooxygenase-2 and inducible nitric oxide synthase expression in thyroid neoplasms and their clinicopathological correlation.

Authors:  Kyung-Hee Kim; Seong-Ho Kim; Seok Hyung Kim; Jong-Ho Back; Mee-Ja Park; Jin-Man Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

4.  Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Hong-Ling Li; Bing-Zhong Sun; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

5.  Dexamethasone damages the rat stomach but not small intestine during inhibition of COX-1.

Authors:  Aya Yokota; Masaki Taniguchi; Yuka Takahira; Akiko Tanaka; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2007-01-13       Impact factor: 3.487

6.  Study of Melatonin as Preventive Agent of Gastrointestinal Damage Induced by Sodium Diclofenac.

Authors:  Aroha B Sánchez; Beatriz Clares; María J Rodríguez-Lagunas; María J Fábrega; Ana C Calpena
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.